Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Certus Gets Funding From Pentagon To Develop Devices That Could Save Lives On The Battlefield

Executive Summary

The US Department of Defense is helping Salt Lake City-based medical device company Certus Critical Care develop AI-enabled technology to treat catastrophic wounds on the battlefield and beyond.

You may also be interested in...



Stryker Fails To Convince FDA To Exempt Patient-Transport Devices

The US agency didn’t buy Stryker’s argument in its April petition that there is no data suggesting patient-transport devices have a history of false and misleading claims.

Bipartisan Bill Seeks To Address US Supply Chain Issues, Prevent Further Crises

Lawmakers have introduced legislation that would establish a national database to help manufacturers expedite the supply chain and avoid further disruptions.

FDA Stamps Recall Of Teleflex Percutaneous Thrombolytic Device As Class I

The US FDA has designated a September recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as high-risk class I.

Topics

UsernamePublicRestriction

Register

MT144633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel